Featured Suppliers:

WASHINGTON (AP) -- President Barack Obama's top aides met frequently with lobbyists and health care industry heavyweights as his administration pieced together a national health care

http://finance.yahoo.com/news/AP-IMPACT-A-stream-of-WH-apf-1078696244.html?x=0&.v=15

Sitting Atop An Earnings Powder Keg (at Forbes.com)

News | www.forbes.com | 5 hours 40 minutes ago

Cutting costs to the bone and beyond at the end of last year lights the fuse for an upcoming earnings explosion.

http://www.forbes.com/2009/11/25/schering-plough-levittown-personal-finance-financial-adviser-network-pfizer-merck.html?partner=yahootix

Incyte Shares Up on Novartis Licensing Deal

News | www.foxbusiness.com | 5 hours 57 minutes ago

Shares of Incyte Corp were up after the company reached a deal with Novartis for access to therapies.

http://www.foxbusiness.com/story/markets/industries/health-care/incyte-novartis-deal/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29

Biotech Stocks: Incyte, Idera move on Novartis deals (at MarketWatch)

News | www.marketwatch.com | 7 hours 48 minutes ago

Shares of Incyte stand out in pre-holiday trading, rallying on a drug-development deal reached with Novartis.

http://www.marketwatch.com/story/incyte-idera-move-on-novartis-deals-2009-11-25?siteid=yhoof

Tiny Incyte Gets Boost From Novartis Deal (at Minyanville.com)

News | www.minyanville.com | 9 hours 5 minutes ago

Tis the season for pharmaceutical deals as drug-makers try to pad their pipeline with promising compounds. Wednesday morning, Novartis (NVS) penned a deal with Delaware-based Incyte (INCY) for

http://www.minyanville.com/articles/pharmaceutical-novartis-merck-pfizer-incyte-janus-kinase-pharma-pharmaceutical-drugs/index/a/25638/from/yahoo

Novartis Deal Gives Incyte a Boost (at Seeking Alpha)

News | seekingalpha.com | 9 hours 43 minutes ago

Interestingly, this deal has been forged only a couple of weeks ahead of the release of a tranche of phase II data on the drug, due to be presented at the American Society of Hematology (ASH) meeting.

http://seekingalpha.com/article/175325-novartis-deal-gives-incyte-a-boost?source=yahoo

Merck, Idera Extend Vaccine Pact

News | www.contractpharma.com | 13 hours 33 minutes ago

Merck, through an affiliate, has extended its research collaboration with Idera Pharmaceuticals, Inc. for a fourth year.

http://www.contractpharma.com/news/2009/11/25/merck%2c_idera_extend_vaccine_pact?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+ContractPharmaBreakingNews+%28Contract+Pharma+Breaking+News%29

Idera Pharmaceuticals, Inc., Novartis Corporation Announces Termination of Asthma and Allergy Research Collaboration Agreement

News | www.biospace.com | 14 hours 50 minutes ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc., today announced that Novartis will terminate its research collaboration agreement with the Company, effective as of February 21, 2010.

http://www.biospace.com/news_story.aspx?StoryID=163912&full=1

Week of Nov. 23, 2009: Pfizer Collaborates to Fight Neglected Diseases; Patheon Names VP of Puerto Rico Operations; More...

News | pharmtech.findpharma.com | 21 hours 50 minutes ago

Company and People Notes: Merck KGaA to build RD hub in Beijing; Depomed appoints VP of operations; more...

http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-23-2009-Pfizer-Collaborates-to-Fight-N/ArticleStandard/Article/detail/643774?ref=25

Vaccine Makers Struggle to Speed Output (at The Wall Street Journal Online)

News | online.wsj.com | Nov 25, 2009

A new Novartis vaccine plant in North Carolina is supposed to boost the U.S.'s ability to fight pandemics, but it won't be pumping out flu shots for at least another two years.

http://online.wsj.com/article/SB125911113742763271.html?ru=yahoo&mod=yahoo_hs